THE Federal Court of Australia has found that Evolution Supplements Australia and its director, Cumhur Keskin, "unlawfully advertised prescription-only substances and therapeutic goods not in the Australian Register of Therapeutic Goods to consumers".
The company promoted Selective Androgen Receptor Modulators (SARMs) which are "experimental medicines...and no SARM has been approved for human use," the TGA said.
The court's judgement last week prevents the company and Keskin from engaging in consumer advertising of Prescription-Only substances for five years, and ordered the company to pay costs.
A further hearing will be held to determine the penalties that should be paid in relation to this matter.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Feb 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Feb 21
